Replimune Group (REPL) PT Raised at Piper Sandler; 'Raising Numbers After Multiple Recent Updates'
Tweet Send to a Friend
Piper Sandler analyst Allison Bratzel raised the price target on Replimune Group (NASDAQ: REPL) to $22.00 (from $14.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
